These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26524)

  • 1. Formation of sulfone metabolites from chlorpromazine and perazine in man.
    Breyer-Pfaff U; Kreft H; Rassner H; Prox A
    Drug Metab Dispos; 1978; 6(2):114-9. PubMed ID: 26524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of the sulfone metabolite of didesmethylchlorpromazine in the rat in vivo and in vitro.
    Kreft H; Breyer-Pfaff U
    Drug Metab Dispos; 1979; 7(6):404-10. PubMed ID: 43228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biotransformation of Chlorphenethazin (Elroquil, Marophen)].
    Pfeifer S; Franke P
    Pharmazie; 1985 Jan; 40(1):37-9. PubMed ID: 2859615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photo-decomposition and metabolism of the phenothiazine drug perazine.
    Schley J
    Arzneimittelforschung; 1986 Apr; 36(4):635-7. PubMed ID: 2872901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological studies on perazine and its primary metabolites.
    Brand U; Menge HG; Neumann BW; Stille G
    Pharmacopsychiatry; 1989 Nov; 22(6):255-7. PubMed ID: 2575764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolism and excretion of the neuroleptic drug perazine in healthy volunteers].
    Schley J; Riedel E; Müller-Oerlinghausen B
    Int Pharmacopsychiatry; 1981; 16(4):201-11. PubMed ID: 6121765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity binding of perazine and desmethylperazine to human alpha 1-acid glycoprotein.
    Schley J; Nündel M; Siegert M; Riedel E; Müller-Oerlinghausen B
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):144-5. PubMed ID: 6104826
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of 35S-perazine in the bile fistula rat.
    Breyer U; Jahns I; Irmscher G; Rassner H; Rehmer S
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):47-56. PubMed ID: 22822
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
    Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
    Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoinduction of the metabolism of phenothiazine neuroleptics in a primary culture of human hepatocytes.
    Wójcikowski J; Maurel P; Daniel WA
    Pharmacol Rep; 2012; 64(6):1578-83. PubMed ID: 23406770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative characteristics of fluorasizine metabolism in different species of animals and man].
    Vikhliaev IuI; Zherdev VP
    Farmakol Toksikol; 1975; 38(6):664-9. PubMed ID: 6307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
    Mutlib AE; Jurcak J; Hrib N
    Drug Metab Dispos; 1996 Oct; 24(10):1139-50. PubMed ID: 8894517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution interactions between perazine and antidepressant drugs. In vivo studies.
    Wójcikowski J; Daniel WA
    Pol J Pharmacol; 2000; 52(6):449-57. PubMed ID: 11334238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The biotransformation of the immunostimulant 3-(2-mercaptoethyl)quinazoline-2,4(1H,3H)-dione (AWD 100-041)].
    Langner A; Kempa S; Nerlich C; Franke P; Pfeifer S
    Pharmazie; 1994; 49(2-3):169-75. PubMed ID: 8171080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New metabolites of sulfinpyrazone in man.
    Dieterle W; Faigle JW; Moppert J
    Arzneimittelforschung; 1980; 30(6):989-93. PubMed ID: 7191279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of binding process of chlorpromazine to bovine serum albumin by means of passive and active experiments.
    Rukhadze MD; Bezarashvili GS; Sidamonidze NS; Tsagareli SK
    Biomed Chromatogr; 2001 Oct; 15(6):365-73. PubMed ID: 11559920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
    Termińska K; Mrowiec W
    Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.